337 related articles for article (PubMed ID: 29033929)
1. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.
Paquissi FC
Front Immunol; 2017; 8():1195. PubMed ID: 29033929
[TBL] [Abstract][Full Text] [Related]
2. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
[TBL] [Abstract][Full Text] [Related]
3. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis.
Sun HQ; Zhang JY; Zhang H; Zou ZS; Wang FS; Jia JH
J Viral Hepat; 2012 Jun; 19(6):396-403. PubMed ID: 22571901
[TBL] [Abstract][Full Text] [Related]
4. The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis.
Weng HL; Liu Y; Chen JL; Huang T; Xu LJ; Godoy P; Hu JH; Zhou C; Stickel F; Marx A; Bohle RM; Zimmer V; Lammert F; Mueller S; Gigou M; Samuel D; Mertens PR; Singer MV; Seitz HK; Dooley S
Hepatology; 2009 Jul; 50(1):230-43. PubMed ID: 19441105
[TBL] [Abstract][Full Text] [Related]
5. The Th17/IL-17 Axis and Kidney Diseases, With Focus on Lupus Nephritis.
Paquissi FC; Abensur H
Front Med (Lausanne); 2021; 8():654912. PubMed ID: 34540858
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.
Meng P; Zhao S; Niu X; Fu N; Su S; Wang R; Zhang Y; Qiao L; Nan Y
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428948
[TBL] [Abstract][Full Text] [Related]
7. Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B.
Su ZJ; Yu XP; Guo RY; Ming DS; Huang LY; Su ML; Deng Y; Lin ZZ
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):437-44. PubMed ID: 23747030
[TBL] [Abstract][Full Text] [Related]
8. Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets.
Paquissi FC
Front Immunol; 2016; 7():490. PubMed ID: 27891128
[TBL] [Abstract][Full Text] [Related]
9. High level of IL-27 positively correlated with Th17 cells may indicate liver injury in patients infected with HBV.
Zhang GL; Xie DY; Ye YN; Lin CS; Zhang XH; Zheng YB; Huang ZL; Peng L; Gao ZL
Liver Int; 2014 Feb; 34(2):266-73. PubMed ID: 23890319
[TBL] [Abstract][Full Text] [Related]
10. Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B.
Liu B; Gao W; Zhang L; Wang J; Chen M; Peng M; Ren H; Hu P
Int Immunopharmacol; 2017 May; 46():48-55. PubMed ID: 28259000
[TBL] [Abstract][Full Text] [Related]
11. Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.
Ming D; Yu X; Guo R; Deng Y; Li J; Lin C; Su M; Lin Z; Su Z
Viral Immunol; 2015 May; 28(4):209-16. PubMed ID: 25710085
[TBL] [Abstract][Full Text] [Related]
12. A deleterious role for Th9/IL-9 in hepatic fibrogenesis.
Qin SY; Lu DH; Guo XY; Luo W; Hu BL; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX; Zhou Y
Sci Rep; 2016 Jan; 6():18694. PubMed ID: 26728971
[TBL] [Abstract][Full Text] [Related]
13. IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation.
Tan Z; Qian X; Jiang R; Liu Q; Wang Y; Chen C; Wang X; Ryffel B; Sun B
J Immunol; 2013 Aug; 191(4):1835-44. PubMed ID: 23842754
[TBL] [Abstract][Full Text] [Related]
14. Correlation between Th17 and nTreg cell frequencies and the stages of progression in chronic hepatitis B.
Yang C; Cui F; Chen LM; Gong XY; Qin B
Mol Med Rep; 2016 Jan; 13(1):853-9. PubMed ID: 26648026
[TBL] [Abstract][Full Text] [Related]
15. Th17 and IL-17 immunity in chronic hepatitis C infection.
Bălănescu P; Lădaru A; Voiosu T; Nicolau A; Ene M; Bălănescu E
Rom J Intern Med; 2012; 50(1):13-8. PubMed ID: 22788089
[TBL] [Abstract][Full Text] [Related]
16. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
Zhang JY; Zhang Z; Lin F; Zou ZS; Xu RN; Jin L; Fu JL; Shi F; Shi M; Wang HF; Wang FS
Hepatology; 2010 Jan; 51(1):81-91. PubMed ID: 19842207
[TBL] [Abstract][Full Text] [Related]
19. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection.
Yang B; Wang Y; Zhao C; Yan W; Che H; Shen C; Zhao M
Immunol Lett; 2013 Jan; 149(1-2):41-9. PubMed ID: 23237940
[TBL] [Abstract][Full Text] [Related]
20. Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.
Bortolami M; Kotsafti A; Cardin R; Farinati F
J Viral Hepat; 2008 Jul; 15(7):515-22. PubMed ID: 18331250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
